Skip to main content
Jairam Krishnamurthy, MD, Oncology, Omaha, NE

JairamKrishnamurthyMD

Oncology Omaha, NE

Physician

Dr. Krishnamurthy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Krishnamurthy's full profile

Already have an account?

  • Office

    Emile 42nd St
    Omaha, NE 68198
    Phone+1 402-559-5600
    Fax+1 402-559-6615

Education & Training

  • University of Nebraska Medical Center College of Medicine
    University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Creighton University School of Medicine (Omaha)
    Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 2010 - 2012
  • Carle Foundation Hospital
    Carle Foundation HospitalInternship, Internal Medicine, 2009 - 2010
  • All India Institute of Medical Sciences
    All India Institute of Medical SciencesClass of 2005

Certifications & Licensure

  • NE State Medical License
    NE State Medical License 2013 - 2026
  • MO State Medical License
    MO State Medical License 2015 - 2017
  • IL State Medical License
    IL State Medical License 2009 - 2012
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • ‘Health Care Works Are Exhausted,’ UNMC Letter Receives 2k+ Signatures
    ‘Health Care Works Are Exhausted,’ UNMC Letter Receives 2k+ SignaturesNovember 18th, 2020
  • 'I'm Just Trying to Get the Word Out': Widow Spreads Message of Male Breast Cancer
    'I'm Just Trying to Get the Word Out': Widow Spreads Message of Male Breast CancerNovember 4th, 2020
  • Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
    Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01February 15th, 2024

Professional Memberships